Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,486 | 12,329 | 16,534 | 6,341 | 14,814 |
| Receivables | 16 | 1,090 | 22 | 717 | 184 |
| Other current assets | 2,957 | 992 | 3,770 | 3,374 | 3,137 |
| TOTAL | $9,459 | $16,301 | $20,326 | $10,432 | $18,135 |
| Non-Current Assets | |||||
| PPE Net | 18,446 | 18,988 | 16,517 | 14,703 | 14,271 |
| Other Non-Current Assets | 4,501 | 4,615 | 2,980 | 3,487 | 3,189 |
| TOTAL | $22,947 | $23,603 | $19,497 | $18,190 | $17,460 |
| Total Assets | $32,406 | $39,904 | $39,823 | $28,622 | $35,595 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,876 | 3,210 | 2,900 | 2,491 | 2,590 |
| Accrued Expenses | 564 | 5,289 | 842 | 1,939 | 1,441 |
| Other current liabilities | 8,333 | 1,703 | 5,176 | 2,953 | 1,770 |
| TOTAL | $19,628 | $18,018 | $12,232 | $11,428 | $9,558 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,000 | 4,000 | N/A | N/A | N/A |
| Deferred Revenues | 2,668 | 5,310 | 754 | 1,559 | 1,320 |
| Other Non-Current Liabilities | 125 | 237 | 0 | 0 | 0 |
| TOTAL | $6,041 | $6,465 | $2,911 | $3,454 | $4,104 |
| Total Liabilities | $25,669 | $24,483 | $15,143 | $14,882 | $13,662 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,960 | 19,371 | 19,108 | 16,036 | 16,003 |
| Common Shares | 19 | 19 | 19 | 16 | 16 |
| Retained earnings | -127,351 | -108,394 | -97,037 | -87,028 | -78,601 |
| Other shareholders' equity | -10 | -53 | 0 | 0 | -1 |
| TOTAL | $6,737 | $15,421 | $24,680 | $13,740 | $21,933 |
| Total Liabilities And Equity | $32,406 | $39,904 | $39,823 | $28,622 | $35,595 |